Market Overview:

According to IMARC Group's latest research publication, "Elastography Imaging Market Report by Modality (Ultrasound, Magnetic Resonance), Application (Radiology, Cardiology, Obstetrics, Urology, Vascular, Orthopedic and Musculoskeletal, and Others), End Use (Hospitals, Ambulatory Surgery Centers, and Others), and Region", the global elastography imaging market size reached USD 4,803.9 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 8,848.7 Million by 2034, exhibiting a growth rate (CAGR) of 6.81% during 2026-2034, supported by ongoing developments in diagnostic procedures and the increasing need for minimally invasive imaging solutions. Rising product applications in cardiology and oncology, growing patient awareness about early diagnosis, and rapid utilization in hospitals are also fueling growth.

This detailed analysis primarily encompasses industry size, business trends, market share, key growth factors, and regional forecasts. The report offers a comprehensive overview and integrates research findings, market assessments, and data from different sources. It also includes pivotal market dynamics like drivers and challenges, while also highlighting growth opportunities, financial insights, technological improvements, emerging trends, and innovations. Besides this, the report provides regional market evaluation, along with a competitive landscape analysis.

How AI is Reshaping the Future of Elastography Imaging Market

  • AI and machine learning are improving the precision and workflow efficiency of elastography, helping radiologists interpret tissue stiffness maps faster for conditions such as liver fibrosis, breast lesions, and thyroid nodules.
  • Government reimbursement frameworks support adoption of advanced imaging. Profitable reimbursement schemes of the American government and a well-established regulatory landscape help North American providers invest in AI-enabled diagnostic devices.
  • Companies like Samsung Medison acquired 100% of Sonio SAS, a specialist in fetal ultrasound AI software, to strengthen its position in advanced ultrasound and diagnostic imaging.
  • Portable and point-of-care elastography devices, paired with AI-guided image acquisition, extend liver and cancer screening beyond large hospitals and reduce dependence on skilled operators.
  • With liver diseases responsible for approximately 2 million deaths per year worldwide, AI-supported elastography offers a scalable, non-invasive alternative to biopsy for early screening.

Grab a sample copy of this report: https://www.imarcgroup.com/elastography-imaging-market/requestsample

Key Trends in the Elastography Imaging Market

  • Advancements in Imaging Technology: Shear wave and strain elastography now deliver better resolution and more precise tissue stiffness evaluation. Liver diseases account for approximately 2 million deaths per year, or about 4% of all global deaths, which keeps pushing innovation in diagnostic imaging.
  • Increasing Demand for Non-Invasive Diagnostics: Providers and patients are replacing conventional biopsy with elastography for real-time evaluation without tissue sampling. Ultrasound elastography is regarded as one of the most accurate non-invasive technologies for tracking changes in tissue stiffness and elasticity.
  • Heightening Prevalence of Chronic Diseases: The National Cancer Institute projects new cancer cases to rise to 29.9 million annually, with 15.3 million deaths. This drives hospitals to invest in cutting-edge elastography devices for early detection.
  • Next-Generation Product Launches: Echosens launched its new FibroScan system featuring Guided Vibration-Controlled Transient Elastography for non-invasive, efficient, and highly accurate liver assessment.
  • Strategic Collaborations and Acquisitions: Players are partnering with healthcare providers and acquiring complementary businesses to build advanced elastography devices and expand their footprint.

Growth Factors in the Elastography Imaging Market

  • Rising Prevalence of Liver Disorders and Cancer: In the United States alone, 2,001,140 new cancer cases are projected to be diagnosed, with an estimated 611,720 deaths, creating strong demand for non-invasive screening.
  • Technological Innovations: Point-of-care and portable elastography devices improve diagnostic abilities, while innovations in magnetic resonance and ultrasound elastography broaden clinical applications.
  • Investments in Healthcare Infrastructure: Growing spending on hospitals, R&D, and early diagnosis supports adoption, helped by favorable financial policies in numerous regions.
  • Ultrasound Product Launches: Mindray launched the Hepatus 6 Diagnostic Ultrasound System with visual transient elastography technology, designed specifically for non-invasive liver assessment.
  • Growing Patient Awareness: Rising awareness of early diagnosis and less painful, time-saving methods is shifting demand toward elastography in oncology and liver care.

Leading Companies Operating in the Global Elastography Imaging Industry:

  • Canon Medical Systems Corporation (Canon Inc.)
  • Esaote SpA
  • Fujifilm Holdings Corporation
  • GE HealthCare
  • Hitachi, Ltd.
  • Hologic, Inc.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Siemens Healthineers AG (Siemens AG)
  • SonoScape Medical Corp

Elastography Imaging Market Report Segmentation:

Breakup By Modality:

  • Ultrasound
  • Magnetic Resonance

Ultrasound accounts for the majority of the market share owing to its non-invasive profile, multi-functionality, cost-efficiency, and growing portable device options.

Breakup By Application:

  • Radiology
  • Cardiology
  • Obstetrics
  • Urology
  • Vascular
  • Orthopedic and Musculoskeletal
  • Others

Radiology holds the largest share due to its crucial role in non-invasive diagnostics, including early detection of tumors, fibrosis, and musculoskeletal disorders.

Breakup By End Use:

  • Hospitals
  • Ambulatory Surgery Centers
  • Others

Hospitals lead the market owing to their widespread use of innovative diagnostic techniques and their ability to manage high patient inflow.

Breakup By Region:

  • North America (United States, Canada)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa

North America enjoys the leading position owing to rising cancer and liver disease cases, strong healthcare infrastructure, early adoption of high-tech diagnostics, substantial R&D investment, and favorable reimbursement.

Recent News and Developments in Elastography Imaging Market

  • Echosens, a non-invasive medical devices company, launched its next-generation FibroScan system featuring Guided Vibration-Controlled Transient Elastography imaging technology for non-invasive, efficient, and highly accurate liver assessment.
  • Siemens Healthineers announced plans to acquire the diagnostic division of Novartis for USD 224 million, expanding its foothold in Europe and strengthening its position in medical imaging.
  • Samsung Medison announced the 100% acquisition of Sonio SAS, a company specialized in fetal ultrasound AI software technology, to fortify its leadership in advanced medical devices.
  • Mindray launched the Hepatus 6 Diagnostic Ultrasound System integrated with visual transient elastography technology for non-invasive liver assessment.

Note: If you require specific details, data, or insights that are not currently included in the scope of this report, we are happy to accommodate your request. As part of our customization service, we will gather and provide the additional information you need, tailored to your specific requirements. Please let us know your exact needs, and we will ensure the report is updated accordingly to meet your expectations.

About Us:

IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-201971-6302